Article
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance.
International journal of hematology - 1 Jan 2022
Han Wenmin, Zhou Feng, Wang Zheng, Hua Haiying, Qin Wei, Jia Zhuxia, Cai Xiaohui, Chen Meiyu, Liu Jie, Chao Hongying, Lu Xuzhang
Abstract excerpt
We evaluated the mutational landscape of chronic myelomonocytic leukemia (CMML) and its potential clinical significance. We analyzed 47 samples with a panel of 112 genes using next-generation sequencing. Forty-five of the 47 patients (95.74%) had at least one mutation identified, with an average of 3.7 (range 0-9) per patient. The most common mutation was NRAS, followed by ASXL1, TET2, SRSF2, RUNX1, KRAS, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
